The analysis of tumor tissue lysates from patients who had neoadjuvant therapy revealed that there was an increase in the expression of pro-angiogenic proteins [Matrix metallopeptidase (MMP9), MMP8, and IL-8] in tumors with a greater level of MDSCs. This evidence concerns the gene MMP9 and neoplasm.